publication venue for Expert Discussion: HER2-Positive Breast Cancer.. 16. 2021 PARP Inhibitors in Breast Cancer: Why, How, and When?. 13. 2018 Therapeutic Advances and New Directions for Triple-Negative Breast Cancer. 2017